Skip to main content
Premium Trial:

Request an Annual Quote

Structural Bioinformatics to Work with Japanese Pharma in Drug Design

Premium

SAN DIEGO, Calif.--Structural Bioinformatics here has signed an agreement with an unnamed Japanese pharmaceutical company to use its Dynapharm technology to design novel compounds. The Japanese partner has requested anonymity, according to Structural Bioinformatics officials.

"SBI has extended its reach into Asia Pacific with this collaboration," noted Edward Maggio, the company's president and CEO. "The strategic fit with our new partner is particularly good, and the project is an important application of our ability to do virtual chemical screening with SBI's dynamically modeled templates of protein active sites." Specifically, the deal involves SBI using bioinformatics to screen and identify low molecular weight compounds that interact with a certain target receptor protein. The Japanese company will test the activities of identified compounds, then both companies will screen and synthesize compounds with greater activity, in hopes of quickly discovering a promising drug lead.

The deal is Structural Bioinfor matics' second corporate alliance; it is also collaborating with the Canadian company BioChem Pharma, as well as doing its own lead discovery and development. Structural Bioinformatics has developed a supercomputational operating system that makes possible the immediate, practical use of genomic data in a variety of structure-based drug discovery and design processes, and is pursuing collaborations with pharmaceutical, gene discovery, and combinatorial chemistry companies.

Filed under

The Scan

Single-Cell Sequencing Points to Embryo Mosaicism

Mosaicism may affect preimplantation genetic tests for aneuploidy, a single-cell sequencing-based analysis of almost three dozen embryos in PLOS Genetics finds.

Rett Syndrome Mouse Model Study Points to RNA Editing Possibilities

Investigators targeted MECP2 in mutant mouse models of Rett syndrome, showing in PNAS that they could restore its expression and dial down symptoms.

Investigators Find Shared, Distinct Genetic Contributors to Childhood Hodgkin Lymphoma

An association study in JAMA Network Open uncovers risk variants within and beyond the human leukocyte antigen locus.

Transcriptomic, Epigenetic Study Appears to Explain Anti-Viral Effects of TB Vaccine

Researchers report in Science Advances on an interferon signature and long-term shifts in monocyte cell DNA methylation in Bacille Calmette-Guérin-vaccinated infant samples.